eli lilly and company

News

Eli Lilly raises price of Mounjaro obesity drug

Eli Lilly signs $1.3 billion deal with Superluminal to use AI to make obesity medicines

Lilly will receive exclusive rights to develop and commercialize drug candidates discovered using Superluminal's AI-driven platform.

Irish Independent on MSN · 1d

Eli Lilly raises price of Mounjaro obesity drug in UK

Eli Lilly is to raise the UK list price of its weight-loss and type 2 diabetes treatment Mounjaro by up to 170pc to be in line with other European markets, it has said, as the pharma industry responds to US pressure to equalise drug prices across markets.

Health and Me on MSN · 2d

Mounjaro Price Hike: Here's All That You Need To Know About This Weightloss Drug

Eli Lilly will hike UK prices of diabetes and weight-loss drug Mounjaro by up to 170% from September, affecting private patients but not the NHS. Mounjaro aids blood sugar control and weight loss, but cost increases may force many to reconsider long-term treatment despite its significant health benefits and convenience.

BioSpace2d

Eli Lilly Keeps Obesity Pipeline Fresh With $1.3B Superluminal Partnership

The Boston-based AI/ML startup focuses on endocrine and cardiometabolic diseases and will use that expertise to generate new ...

9don MSN

Eli Lilly Shares Plummet 14% Toward Worst Day In 25 Years—Here’s Why It’s Down

Eli Lilly on Thursday released data for its daily obesity pill, orforglipron, which found the medication helped obese or ...

PharmExec1d

Superluminal Medicines and Eli Lilly Form $1.3 Billion Collaboration Advancing Small Molecule Therapeutics

Superluminal partners with Eli Lilly to develop AI-driven small molecule therapies targeting GPCRs for obesity and ...

3don MSN

Eli Lilly insider buying from CEO and others jump amid selloff

Eli Lilly (LLY) stock recovers as company executives seize a rare buying opportunity to make a series of insider purchases ...

14hon MSN

Is Eli Lilly Stock a Buy? Here's What the Market Isn't Pricing in Yet.

Viking Therapeutics' dual-formulation obesity program could capture the most profitable patient segment starting in 2027. At 29 times forward earnings, Lilly stock assumes flawless execution with no ...

1don MSN

Eli Lilly hikes Mounjaro prices in the UK to make weight-loss drug cheaper in the US

Eli Lilly will significantly increase the price of its weight-loss drug Mounjaro in the United Kingdom in a bid to bring down ...

Weight-loss weariness and Trump threats wipe $250bn off Novo Nordisk and Eli Lilly

Trump’s push for price cuts and tariffs weighs on ‘obesity franchises’, which have missed out on equity market’s rise ...

2don MSN

Eli Lilly hikes price of diabetes drug Mounjaro in UK as Trump pressures pharma to align drug costs

It comes as President Donald Trump pressures drugmakers to lower U.S. drug prices while hiking them abroad under a policy ...

Eli Lilly: The Bears Have Spoken Loud And Clear (Upgrade)

Eli Lilly and Company faces valuation pressure after disappointing Orforglipron results. Click here to read an analysis of ...

2don MSN